DUBLIN--(BUSINESS WIRE)--The "Cerebrospinal Fluid (CSF) Management Market by Product (Shunts (Ventriculoperitoneal, Ventriculoatrial, Adjustable Valve), External Drainage Systems (EVD, Lumbar Drainage)), End User (Pediatric, Adult, Geriatric) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.
The Global Cerebrospinal Fluid (CSF) Management Market is Projected to Reach USD 1.56 Billion By 2022 from an Estimated USD 1.26 Billion in 2017, at a CAGR Of 4.4%.
The high prevalence of hydrocephalus and the subsequent increase in the number of shunting procedures and the growing geriatric population are factors driving the growth of this market. The growing healthcare market in developing economies is also expected to provide growth opportunities for players in the market. However, the dearth of trained professionals and complications related to CSF shunts may challenge market growth during the forecast period to a certain extent.
The market is segmented by product into shunts and external drainage systems. The shunts segment is expected to grow at highest CAGR during the forecast period. This can be attributed to growing number of shunting procedures performed worldwide as well as the increasing number of revision shunt surgeries being performed due to shunt malfunction and infection.
Based on end user, the global cerebrospinal fluid (CSF) management market is segmented into pediatric, adult, and geriatric end users. The pediatric segment is expected to grow at the highest CAGR during the forecast period and this growth is attributed to the high prevalence of congenital hydrocephalus along with the rising number of shunting procedures performed in the pediatric population.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Cerebrospinal Fluid (CSF) Management Market, By Product
7 Cerebrospinal Fluid Management Market, By End User
8 Cerebrospinal Fluid Management Market, By Region
9 Market Share Analysis
10 Company Profiles
- Argi Grup
- B. Braun Melsungen
- Dispomedica GmbH
- G.SURGIWEAR LTD
- Integra Lifesciences Holdings Corporation
- Moller Medical GmbH
- Natus Medical Incorporated
- SOPHYSA (A Subsidiary of TKB Group)
- Spiegelberg GmbH & Co. Kg
- Wellong Instruments Co., Ltd
For more information about this report visit https://www.researchandmarkets.com/research/8bfxw6/cerebrospinal?w=4